nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—NFATC1—osteoporosis	0.706	0.895	CbGaD
Pseudoephedrine—TNF—osteoporosis	0.0829	0.105	CbGaD
Pseudoephedrine—NFATC1—periosteum—osteoporosis	0.018	0.719	CbGeAlD
Pseudoephedrine—IL2—uterus—osteoporosis	0.00225	0.0899	CbGeAlD
Pseudoephedrine—NFATC1—bone marrow—osteoporosis	0.00209	0.0835	CbGeAlD
Pseudoephedrine—IL2—bone marrow—osteoporosis	0.00191	0.0763	CbGeAlD
Pseudoephedrine—Confusional state—Calcium Acetate—osteoporosis	0.00065	0.00766	CcSEcCtD
Pseudoephedrine—Anorexia—Calcium Acetate—osteoporosis	0.000615	0.00725	CcSEcCtD
Pseudoephedrine—Lightheadedness—Conjugated Estrogens—osteoporosis	0.000607	0.00715	CcSEcCtD
Pseudoephedrine—Hypertension—Ergocalciferol—osteoporosis	0.000603	0.0071	CcSEcCtD
Pseudoephedrine—Dysuria—Estropipate—osteoporosis	0.000602	0.0071	CcSEcCtD
Pseudoephedrine—Hallucination—Etidronic acid—osteoporosis	0.000593	0.00699	CcSEcCtD
Pseudoephedrine—Irritability—Ethinyl Estradiol—osteoporosis	0.000577	0.0068	CcSEcCtD
Pseudoephedrine—Decreased appetite—Calcium Acetate—osteoporosis	0.000561	0.00661	CcSEcCtD
Pseudoephedrine—Pain—Calcium Acetate—osteoporosis	0.000552	0.0065	CcSEcCtD
Pseudoephedrine—Psychotic disorder—Pamidronate—osteoporosis	0.000547	0.00644	CcSEcCtD
Pseudoephedrine—Anorexia—Ergocalciferol—osteoporosis	0.000543	0.0064	CcSEcCtD
Pseudoephedrine—Blood pressure increased—Estradiol—osteoporosis	0.000543	0.0064	CcSEcCtD
Pseudoephedrine—Sweating—Raloxifene—osteoporosis	0.000533	0.00629	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Calcium Acetate—osteoporosis	0.000532	0.00626	CcSEcCtD
Pseudoephedrine—Sweating—Ibandronate—osteoporosis	0.000528	0.00622	CcSEcCtD
Pseudoephedrine—Muscle spasms—Etidronic acid—osteoporosis	0.000499	0.00588	CcSEcCtD
Pseudoephedrine—Angina pectoris—Risedronate—osteoporosis	0.000496	0.00584	CcSEcCtD
Pseudoephedrine—Decreased appetite—Ergocalciferol—osteoporosis	0.000495	0.00584	CcSEcCtD
Pseudoephedrine—Dysuria—Ethinyl Estradiol—osteoporosis	0.000488	0.00575	CcSEcCtD
Pseudoephedrine—Pain—Ergocalciferol—osteoporosis	0.000487	0.00574	CcSEcCtD
Pseudoephedrine—Irritability—Conjugated Estrogens—osteoporosis	0.00047	0.00554	CcSEcCtD
Pseudoephedrine—Asthenia—Calcium Acetate—osteoporosis	0.000463	0.00545	CcSEcCtD
Pseudoephedrine—MAOA—uterus—osteoporosis	0.000442	0.0177	CbGeAlD
Pseudoephedrine—Tension—Estropipate—osteoporosis	0.000441	0.00519	CcSEcCtD
Pseudoephedrine—Nervousness—Estropipate—osteoporosis	0.000436	0.00514	CcSEcCtD
Pseudoephedrine—Arrhythmia—Calcitriol—osteoporosis	0.000432	0.0051	CcSEcCtD
Pseudoephedrine—Muscle spasms—Estropipate—osteoporosis	0.000432	0.00509	CcSEcCtD
Pseudoephedrine—Confusional state—Etidronic acid—osteoporosis	0.000427	0.00503	CcSEcCtD
Pseudoephedrine—Dizziness—Calcium Acetate—osteoporosis	0.000427	0.00503	CcSEcCtD
Pseudoephedrine—Muscle spasms—Alendronate—osteoporosis	0.000425	0.00501	CcSEcCtD
Pseudoephedrine—Muscle spasms—Raloxifene—osteoporosis	0.000418	0.00493	CcSEcCtD
Pseudoephedrine—Muscle spasms—Ibandronate—osteoporosis	0.000414	0.00488	CcSEcCtD
Pseudoephedrine—Vomiting—Calcium Acetate—osteoporosis	0.00041	0.00483	CcSEcCtD
Pseudoephedrine—Asthenia—Ergocalciferol—osteoporosis	0.000409	0.00482	CcSEcCtD
Pseudoephedrine—Vertigo—Estropipate—osteoporosis	0.000403	0.00475	CcSEcCtD
Pseudoephedrine—Dysuria—Conjugated Estrogens—osteoporosis	0.000398	0.00469	CcSEcCtD
Pseudoephedrine—Vertigo—Alendronate—osteoporosis	0.000397	0.00468	CcSEcCtD
Pseudoephedrine—Palpitations—Estropipate—osteoporosis	0.000397	0.00467	CcSEcCtD
Pseudoephedrine—Vertigo—Raloxifene—osteoporosis	0.000391	0.0046	CcSEcCtD
Pseudoephedrine—Agitation—Calcitriol—osteoporosis	0.000387	0.00456	CcSEcCtD
Pseudoephedrine—Vertigo—Ibandronate—osteoporosis	0.000387	0.00456	CcSEcCtD
Pseudoephedrine—Nausea—Calcium Acetate—osteoporosis	0.000383	0.00452	CcSEcCtD
Pseudoephedrine—Anxiety—Estropipate—osteoporosis	0.000381	0.00449	CcSEcCtD
Pseudoephedrine—Palpitations—Ibandronate—osteoporosis	0.00038	0.00448	CcSEcCtD
Pseudoephedrine—Chest pain—Alendronate—osteoporosis	0.000376	0.00444	CcSEcCtD
Pseudoephedrine—Irritability—Estradiol—osteoporosis	0.000376	0.00443	CcSEcCtD
Pseudoephedrine—Dyspepsia—Etidronic acid—osteoporosis	0.000373	0.00439	CcSEcCtD
Pseudoephedrine—Hypertension—Ibandronate—osteoporosis	0.000372	0.00438	CcSEcCtD
Pseudoephedrine—Chest pain—Raloxifene—osteoporosis	0.00037	0.00436	CcSEcCtD
Pseudoephedrine—Chest pain—Ibandronate—osteoporosis	0.000367	0.00432	CcSEcCtD
Pseudoephedrine—Anxiety—Ibandronate—osteoporosis	0.000365	0.0043	CcSEcCtD
Pseudoephedrine—Arrhythmia—Risedronate—osteoporosis	0.000364	0.00429	CcSEcCtD
Pseudoephedrine—Hypertension—Calcitriol—osteoporosis	0.000364	0.00429	CcSEcCtD
Pseudoephedrine—Bradycardia—Zoledronate—osteoporosis	0.00036	0.00425	CcSEcCtD
Pseudoephedrine—Chest pain—Calcitriol—osteoporosis	0.000359	0.00423	CcSEcCtD
Pseudoephedrine—Anxiety—Calcitriol—osteoporosis	0.000358	0.00421	CcSEcCtD
Pseudoephedrine—Muscle spasms—Ethinyl Estradiol—osteoporosis	0.00035	0.00412	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Etidronic acid—osteoporosis	0.000349	0.00411	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Raloxifene—osteoporosis	0.000343	0.00404	CcSEcCtD
Pseudoephedrine—Muscle spasms—Risedronate—osteoporosis	0.000341	0.00402	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Ibandronate—osteoporosis	0.00034	0.004	CcSEcCtD
Pseudoephedrine—ADRA2A—uterus—osteoporosis	0.000339	0.0136	CbGeAlD
Pseudoephedrine—Nausea—Ergocalciferol—osteoporosis	0.000338	0.00399	CcSEcCtD
Pseudoephedrine—Insomnia—Estropipate—osteoporosis	0.000331	0.0039	CcSEcCtD
Pseudoephedrine—Tension—Pamidronate—osteoporosis	0.000331	0.0039	CcSEcCtD
Pseudoephedrine—Anorexia—Calcitriol—osteoporosis	0.000328	0.00386	CcSEcCtD
Pseudoephedrine—Nervousness—Pamidronate—osteoporosis	0.000328	0.00386	CcSEcCtD
Pseudoephedrine—Muscle spasms—Pamidronate—osteoporosis	0.000324	0.00382	CcSEcCtD
Pseudoephedrine—Dyspepsia—Estropipate—osteoporosis	0.000323	0.0038	CcSEcCtD
Pseudoephedrine—Insomnia—Raloxifene—osteoporosis	0.000321	0.00378	CcSEcCtD
Pseudoephedrine—Vertigo—Risedronate—osteoporosis	0.000319	0.00376	CcSEcCtD
Pseudoephedrine—Insomnia—Ibandronate—osteoporosis	0.000318	0.00374	CcSEcCtD
Pseudoephedrine—Dyspepsia—Alendronate—osteoporosis	0.000318	0.00374	CcSEcCtD
Pseudoephedrine—Arrhythmia—Zoledronate—osteoporosis	0.000316	0.00373	CcSEcCtD
Pseudoephedrine—Pain—Estropipate—osteoporosis	0.000313	0.00369	CcSEcCtD
Pseudoephedrine—Dyspepsia—Raloxifene—osteoporosis	0.000312	0.00368	CcSEcCtD
Pseudoephedrine—Insomnia—Calcitriol—osteoporosis	0.000311	0.00367	CcSEcCtD
Pseudoephedrine—Agitation—Pamidronate—osteoporosis	0.00031	0.00365	CcSEcCtD
Pseudoephedrine—Dyspepsia—Ibandronate—osteoporosis	0.000309	0.00364	CcSEcCtD
Pseudoephedrine—Anxiety—Ethinyl Estradiol—osteoporosis	0.000309	0.00364	CcSEcCtD
Pseudoephedrine—Pain—Alendronate—osteoporosis	0.000309	0.00364	CcSEcCtD
Pseudoephedrine—Hypertension—Risedronate—osteoporosis	0.000306	0.00361	CcSEcCtD
Pseudoephedrine—Decreased appetite—Ibandronate—osteoporosis	0.000305	0.0036	CcSEcCtD
Pseudoephedrine—Arrhythmia—Conjugated Estrogens—osteoporosis	0.000304	0.00359	CcSEcCtD
Pseudoephedrine—Pain—Raloxifene—osteoporosis	0.000304	0.00358	CcSEcCtD
Pseudoephedrine—Chest pain—Risedronate—osteoporosis	0.000302	0.00356	CcSEcCtD
Pseudoephedrine—Anxiety—Risedronate—osteoporosis	0.000301	0.00355	CcSEcCtD
Pseudoephedrine—Pain—Ibandronate—osteoporosis	0.0003	0.00354	CcSEcCtD
Pseudoephedrine—Decreased appetite—Calcitriol—osteoporosis	0.000299	0.00352	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Alendronate—osteoporosis	0.000297	0.0035	CcSEcCtD
Pseudoephedrine—Muscle spasms—Zoledronate—osteoporosis	0.000296	0.00349	CcSEcCtD
Pseudoephedrine—Pain—Calcitriol—osteoporosis	0.000294	0.00347	CcSEcCtD
Pseudoephedrine—Hypertension—Pamidronate—osteoporosis	0.000291	0.00343	CcSEcCtD
Pseudoephedrine—Tension—Conjugated Estrogens—osteoporosis	0.000291	0.00343	CcSEcCtD
Pseudoephedrine—Body temperature increased—Estropipate—osteoporosis	0.00029	0.00341	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Ibandronate—osteoporosis	0.00029	0.00341	CcSEcCtD
Pseudoephedrine—Tremor—Zoledronate—osteoporosis	0.000289	0.0034	CcSEcCtD
Pseudoephedrine—Nervousness—Conjugated Estrogens—osteoporosis	0.000288	0.00339	CcSEcCtD
Pseudoephedrine—Anxiety—Pamidronate—osteoporosis	0.000286	0.00337	CcSEcCtD
Pseudoephedrine—Body temperature increased—Alendronate—osteoporosis	0.000285	0.00336	CcSEcCtD
Pseudoephedrine—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000285	0.00336	CcSEcCtD
Pseudoephedrine—Agitation—Zoledronate—osteoporosis	0.000283	0.00334	CcSEcCtD
Pseudoephedrine—Body temperature increased—Raloxifene—osteoporosis	0.000281	0.00331	CcSEcCtD
Pseudoephedrine—Body temperature increased—Ibandronate—osteoporosis	0.000278	0.00327	CcSEcCtD
Pseudoephedrine—Confusional state—Pamidronate—osteoporosis	0.000278	0.00327	CcSEcCtD
Pseudoephedrine—Vertigo—Zoledronate—osteoporosis	0.000277	0.00326	CcSEcCtD
Pseudoephedrine—Palpitations—Zoledronate—osteoporosis	0.000272	0.00321	CcSEcCtD
Pseudoephedrine—Body temperature increased—Calcitriol—osteoporosis	0.000272	0.0032	CcSEcCtD
Pseudoephedrine—Vomiting—Etidronic acid—osteoporosis	0.000269	0.00317	CcSEcCtD
Pseudoephedrine—Tachycardia—Pamidronate—osteoporosis	0.000269	0.00317	CcSEcCtD
Pseudoephedrine—Rash—Etidronic acid—osteoporosis	0.000267	0.00315	CcSEcCtD
Pseudoephedrine—Dermatitis—Etidronic acid—osteoporosis	0.000267	0.00314	CcSEcCtD
Pseudoephedrine—Vertigo—Conjugated Estrogens—osteoporosis	0.000267	0.00314	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Pamidronate—osteoporosis	0.000266	0.00314	CcSEcCtD
Pseudoephedrine—Hypertension—Zoledronate—osteoporosis	0.000266	0.00313	CcSEcCtD
Pseudoephedrine—Headache—Etidronic acid—osteoporosis	0.000265	0.00313	CcSEcCtD
Pseudoephedrine—Asthenia—Estropipate—osteoporosis	0.000263	0.0031	CcSEcCtD
Pseudoephedrine—Anorexia—Pamidronate—osteoporosis	0.000262	0.00309	CcSEcCtD
Pseudoephedrine—Chest pain—Zoledronate—osteoporosis	0.000262	0.00309	CcSEcCtD
Pseudoephedrine—Palpitations—Conjugated Estrogens—osteoporosis	0.000262	0.00309	CcSEcCtD
Pseudoephedrine—Insomnia—Risedronate—osteoporosis	0.000262	0.00309	CcSEcCtD
Pseudoephedrine—Anxiety—Zoledronate—osteoporosis	0.000261	0.00308	CcSEcCtD
Pseudoephedrine—Asthenia—Alendronate—osteoporosis	0.000259	0.00305	CcSEcCtD
Pseudoephedrine—Dyspnoea—Risedronate—osteoporosis	0.000258	0.00304	CcSEcCtD
Pseudoephedrine—Etomidate—CYP19A1—osteoporosis	0.000258	1	CrCbGaD
Pseudoephedrine—Dyspepsia—Risedronate—osteoporosis	0.000255	0.003	CcSEcCtD
Pseudoephedrine—Confusional state—Zoledronate—osteoporosis	0.000254	0.00299	CcSEcCtD
Pseudoephedrine—Chest pain—Conjugated Estrogens—osteoporosis	0.000253	0.00298	CcSEcCtD
Pseudoephedrine—Asthenia—Ibandronate—osteoporosis	0.000252	0.00297	CcSEcCtD
Pseudoephedrine—Anxiety—Conjugated Estrogens—osteoporosis	0.000252	0.00297	CcSEcCtD
Pseudoephedrine—Nausea—Etidronic acid—osteoporosis	0.000252	0.00296	CcSEcCtD
Pseudoephedrine—Insomnia—Pamidronate—osteoporosis	0.000249	0.00293	CcSEcCtD
Pseudoephedrine—Pain—Risedronate—osteoporosis	0.000248	0.00292	CcSEcCtD
Pseudoephedrine—Asthenia—Calcitriol—osteoporosis	0.000247	0.00291	CcSEcCtD
Pseudoephedrine—Dyspnoea—Pamidronate—osteoporosis	0.000245	0.00289	CcSEcCtD
Pseudoephedrine—Tachycardia—Zoledronate—osteoporosis	0.000245	0.00289	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000245	0.00288	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Zoledronate—osteoporosis	0.000243	0.00286	CcSEcCtD
Pseudoephedrine—Dyspepsia—Pamidronate—osteoporosis	0.000242	0.00285	CcSEcCtD
Pseudoephedrine—Dizziness—Estropipate—osteoporosis	0.000242	0.00285	CcSEcCtD
Pseudoephedrine—Anorexia—Zoledronate—osteoporosis	0.00024	0.00282	CcSEcCtD
Pseudoephedrine—Decreased appetite—Pamidronate—osteoporosis	0.000239	0.00282	CcSEcCtD
Pseudoephedrine—Dizziness—Alendronate—osteoporosis	0.000239	0.00281	CcSEcCtD
Pseudoephedrine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000236	0.00278	CcSEcCtD
Pseudoephedrine—Pain—Pamidronate—osteoporosis	0.000235	0.00277	CcSEcCtD
Pseudoephedrine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000235	0.00277	CcSEcCtD
Pseudoephedrine—Dizziness—Raloxifene—osteoporosis	0.000235	0.00277	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000234	0.00276	CcSEcCtD
Pseudoephedrine—Tension—Estradiol—osteoporosis	0.000233	0.00275	CcSEcCtD
Pseudoephedrine—Vomiting—Estropipate—osteoporosis	0.000233	0.00274	CcSEcCtD
Pseudoephedrine—Dizziness—Ibandronate—osteoporosis	0.000232	0.00274	CcSEcCtD
Pseudoephedrine—Rash—Estropipate—osteoporosis	0.000231	0.00272	CcSEcCtD
Pseudoephedrine—Dermatitis—Estropipate—osteoporosis	0.000231	0.00272	CcSEcCtD
Pseudoephedrine—Anorexia—Conjugated Estrogens—osteoporosis	0.000231	0.00272	CcSEcCtD
Pseudoephedrine—Nervousness—Estradiol—osteoporosis	0.000231	0.00272	CcSEcCtD
Pseudoephedrine—Headache—Estropipate—osteoporosis	0.00023	0.0027	CcSEcCtD
Pseudoephedrine—Vomiting—Alendronate—osteoporosis	0.000229	0.0027	CcSEcCtD
Pseudoephedrine—Body temperature increased—Risedronate—osteoporosis	0.000229	0.0027	CcSEcCtD
Pseudoephedrine—Muscle spasms—Estradiol—osteoporosis	0.000228	0.00269	CcSEcCtD
Pseudoephedrine—Rash—Alendronate—osteoporosis	0.000228	0.00268	CcSEcCtD
Pseudoephedrine—Insomnia—Zoledronate—osteoporosis	0.000227	0.00268	CcSEcCtD
Pseudoephedrine—Dermatitis—Alendronate—osteoporosis	0.000227	0.00268	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Pamidronate—osteoporosis	0.000227	0.00267	CcSEcCtD
Pseudoephedrine—Headache—Alendronate—osteoporosis	0.000226	0.00266	CcSEcCtD
Pseudoephedrine—Vomiting—Raloxifene—osteoporosis	0.000226	0.00266	CcSEcCtD
Pseudoephedrine—Dyspnoea—Zoledronate—osteoporosis	0.000224	0.00264	CcSEcCtD
Pseudoephedrine—Rash—Raloxifene—osteoporosis	0.000224	0.00264	CcSEcCtD
Pseudoephedrine—Dermatitis—Raloxifene—osteoporosis	0.000224	0.00263	CcSEcCtD
Pseudoephedrine—Vomiting—Ibandronate—osteoporosis	0.000223	0.00263	CcSEcCtD
Pseudoephedrine—Tremor—Estradiol—osteoporosis	0.000222	0.00262	CcSEcCtD
Pseudoephedrine—Headache—Raloxifene—osteoporosis	0.000222	0.00262	CcSEcCtD
Pseudoephedrine—Rash—Ibandronate—osteoporosis	0.000222	0.00261	CcSEcCtD
Pseudoephedrine—Dermatitis—Ibandronate—osteoporosis	0.000221	0.00261	CcSEcCtD
Pseudoephedrine—Dyspepsia—Zoledronate—osteoporosis	0.000221	0.00261	CcSEcCtD
Pseudoephedrine—Headache—Ibandronate—osteoporosis	0.00022	0.00259	CcSEcCtD
Pseudoephedrine—Insomnia—Conjugated Estrogens—osteoporosis	0.000219	0.00258	CcSEcCtD
Pseudoephedrine—Vomiting—Calcitriol—osteoporosis	0.000219	0.00258	CcSEcCtD
Pseudoephedrine—Decreased appetite—Zoledronate—osteoporosis	0.000219	0.00258	CcSEcCtD
Pseudoephedrine—Agitation—Estradiol—osteoporosis	0.000218	0.00257	CcSEcCtD
Pseudoephedrine—Nausea—Estropipate—osteoporosis	0.000218	0.00256	CcSEcCtD
Pseudoephedrine—Body temperature increased—Pamidronate—osteoporosis	0.000218	0.00256	CcSEcCtD
Pseudoephedrine—Rash—Calcitriol—osteoporosis	0.000217	0.00256	CcSEcCtD
Pseudoephedrine—Dermatitis—Calcitriol—osteoporosis	0.000217	0.00255	CcSEcCtD
Pseudoephedrine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000216	0.00254	CcSEcCtD
Pseudoephedrine—Headache—Calcitriol—osteoporosis	0.000215	0.00254	CcSEcCtD
Pseudoephedrine—Pain—Zoledronate—osteoporosis	0.000215	0.00253	CcSEcCtD
Pseudoephedrine—Nausea—Alendronate—osteoporosis	0.000214	0.00253	CcSEcCtD
Pseudoephedrine—Vertigo—Estradiol—osteoporosis	0.000213	0.00251	CcSEcCtD
Pseudoephedrine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000213	0.00251	CcSEcCtD
Pseudoephedrine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000213	0.00251	CcSEcCtD
Pseudoephedrine—Nausea—Raloxifene—osteoporosis	0.000211	0.00248	CcSEcCtD
Pseudoephedrine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00021	0.00248	CcSEcCtD
Pseudoephedrine—Palpitations—Estradiol—osteoporosis	0.00021	0.00247	CcSEcCtD
Pseudoephedrine—Nausea—Ibandronate—osteoporosis	0.000209	0.00246	CcSEcCtD
Pseudoephedrine—Asthenia—Risedronate—osteoporosis	0.000208	0.00245	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Zoledronate—osteoporosis	0.000207	0.00244	CcSEcCtD
Pseudoephedrine—Pain—Conjugated Estrogens—osteoporosis	0.000207	0.00244	CcSEcCtD
Pseudoephedrine—Hypertension—Estradiol—osteoporosis	0.000205	0.00242	CcSEcCtD
Pseudoephedrine—Nausea—Calcitriol—osteoporosis	0.000204	0.00241	CcSEcCtD
Pseudoephedrine—Chest pain—Estradiol—osteoporosis	0.000202	0.00238	CcSEcCtD
Pseudoephedrine—Anxiety—Estradiol—osteoporosis	0.000201	0.00237	CcSEcCtD
Pseudoephedrine—Body temperature increased—Zoledronate—osteoporosis	0.000199	0.00234	CcSEcCtD
Pseudoephedrine—Asthenia—Pamidronate—osteoporosis	0.000197	0.00233	CcSEcCtD
Pseudoephedrine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000196	0.00231	CcSEcCtD
Pseudoephedrine—Confusional state—Estradiol—osteoporosis	0.000195	0.0023	CcSEcCtD
Pseudoephedrine—Dizziness—Risedronate—osteoporosis	0.000191	0.00226	CcSEcCtD
Pseudoephedrine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000191	0.00226	CcSEcCtD
Pseudoephedrine—Tachycardia—Estradiol—osteoporosis	0.000189	0.00223	CcSEcCtD
Pseudoephedrine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000189	0.00222	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Estradiol—osteoporosis	0.000187	0.00221	CcSEcCtD
Pseudoephedrine—Rash—Ethinyl Estradiol—osteoporosis	0.000187	0.00221	CcSEcCtD
Pseudoephedrine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000187	0.0022	CcSEcCtD
Pseudoephedrine—Headache—Ethinyl Estradiol—osteoporosis	0.000186	0.00219	CcSEcCtD
Pseudoephedrine—Vomiting—Risedronate—osteoporosis	0.000184	0.00217	CcSEcCtD
Pseudoephedrine—Rash—Risedronate—osteoporosis	0.000183	0.00215	CcSEcCtD
Pseudoephedrine—Dermatitis—Risedronate—osteoporosis	0.000182	0.00215	CcSEcCtD
Pseudoephedrine—Dizziness—Pamidronate—osteoporosis	0.000182	0.00214	CcSEcCtD
Pseudoephedrine—Headache—Risedronate—osteoporosis	0.000181	0.00214	CcSEcCtD
Pseudoephedrine—Asthenia—Zoledronate—osteoporosis	0.00018	0.00213	CcSEcCtD
Pseudoephedrine—Nausea—Ethinyl Estradiol—osteoporosis	0.000176	0.00208	CcSEcCtD
Pseudoephedrine—Insomnia—Estradiol—osteoporosis	0.000175	0.00206	CcSEcCtD
Pseudoephedrine—Vomiting—Pamidronate—osteoporosis	0.000175	0.00206	CcSEcCtD
Pseudoephedrine—Asthenia—Conjugated Estrogens—osteoporosis	0.000174	0.00205	CcSEcCtD
Pseudoephedrine—Rash—Pamidronate—osteoporosis	0.000174	0.00204	CcSEcCtD
Pseudoephedrine—Dermatitis—Pamidronate—osteoporosis	0.000173	0.00204	CcSEcCtD
Pseudoephedrine—Dyspnoea—Estradiol—osteoporosis	0.000173	0.00204	CcSEcCtD
Pseudoephedrine—Headache—Pamidronate—osteoporosis	0.000172	0.00203	CcSEcCtD
Pseudoephedrine—Nausea—Risedronate—osteoporosis	0.000172	0.00203	CcSEcCtD
Pseudoephedrine—Dyspepsia—Estradiol—osteoporosis	0.000171	0.00201	CcSEcCtD
Pseudoephedrine—Decreased appetite—Estradiol—osteoporosis	0.000168	0.00198	CcSEcCtD
Pseudoephedrine—Dizziness—Zoledronate—osteoporosis	0.000166	0.00196	CcSEcCtD
Pseudoephedrine—Pain—Estradiol—osteoporosis	0.000166	0.00195	CcSEcCtD
Pseudoephedrine—Nausea—Pamidronate—osteoporosis	0.000164	0.00193	CcSEcCtD
Pseudoephedrine—Dizziness—Conjugated Estrogens—osteoporosis	0.00016	0.00189	CcSEcCtD
Pseudoephedrine—Vomiting—Zoledronate—osteoporosis	0.00016	0.00188	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Estradiol—osteoporosis	0.00016	0.00188	CcSEcCtD
Pseudoephedrine—Rash—Zoledronate—osteoporosis	0.000159	0.00187	CcSEcCtD
Pseudoephedrine—Dermatitis—Zoledronate—osteoporosis	0.000158	0.00187	CcSEcCtD
Pseudoephedrine—Headache—Zoledronate—osteoporosis	0.000158	0.00186	CcSEcCtD
Pseudoephedrine—Vomiting—Conjugated Estrogens—osteoporosis	0.000154	0.00181	CcSEcCtD
Pseudoephedrine—Body temperature increased—Estradiol—osteoporosis	0.000153	0.0018	CcSEcCtD
Pseudoephedrine—Rash—Conjugated Estrogens—osteoporosis	0.000153	0.0018	CcSEcCtD
Pseudoephedrine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000153	0.0018	CcSEcCtD
Pseudoephedrine—Headache—Conjugated Estrogens—osteoporosis	0.000152	0.00179	CcSEcCtD
Pseudoephedrine—Nausea—Zoledronate—osteoporosis	0.000149	0.00176	CcSEcCtD
Pseudoephedrine—Nausea—Conjugated Estrogens—osteoporosis	0.000144	0.00169	CcSEcCtD
Pseudoephedrine—Asthenia—Estradiol—osteoporosis	0.000139	0.00164	CcSEcCtD
Pseudoephedrine—Dizziness—Estradiol—osteoporosis	0.000128	0.00151	CcSEcCtD
Pseudoephedrine—Vomiting—Estradiol—osteoporosis	0.000123	0.00145	CcSEcCtD
Pseudoephedrine—Rash—Estradiol—osteoporosis	0.000122	0.00144	CcSEcCtD
Pseudoephedrine—Dermatitis—Estradiol—osteoporosis	0.000122	0.00144	CcSEcCtD
Pseudoephedrine—Headache—Estradiol—osteoporosis	0.000121	0.00143	CcSEcCtD
Pseudoephedrine—Nausea—Estradiol—osteoporosis	0.000115	0.00136	CcSEcCtD
Pseudoephedrine—IL2—Immune System—IL1B—osteoporosis	2.04e-05	0.000201	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—OXCT1—osteoporosis	2.04e-05	0.000201	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CA2—osteoporosis	2.04e-05	0.000201	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.02e-05	0.0002	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IGF1—osteoporosis	2.02e-05	0.000199	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—P4HB—osteoporosis	2.02e-05	0.000199	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—LRP6—osteoporosis	2.02e-05	0.000199	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—PTHLH—osteoporosis	2e-05	0.000198	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PTH—osteoporosis	2e-05	0.000197	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CNR2—osteoporosis	1.99e-05	0.000197	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CALCA—osteoporosis	1.99e-05	0.000196	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—MGLL—osteoporosis	1.99e-05	0.000196	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GAPDH—osteoporosis	1.98e-05	0.000196	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—ESR1—osteoporosis	1.97e-05	0.000195	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	1.95e-05	0.000193	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CNR2—osteoporosis	1.95e-05	0.000192	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CALCA—osteoporosis	1.94e-05	0.000192	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—IL6R—osteoporosis	1.94e-05	0.000191	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—RAP1A—osteoporosis	1.93e-05	0.000191	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Biological oxidations—POMC—osteoporosis	1.91e-05	0.000189	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PTH—osteoporosis	1.86e-05	0.000183	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—IRS1—osteoporosis	1.84e-05	0.000182	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—POMC—osteoporosis	1.84e-05	0.000182	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—WNT1—osteoporosis	1.83e-05	0.000181	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—PTHLH—osteoporosis	1.83e-05	0.00018	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	1.82e-05	0.000179	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CNR2—osteoporosis	1.81e-05	0.000179	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CALCA—osteoporosis	1.8e-05	0.000178	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PKM—osteoporosis	1.8e-05	0.000178	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—FDPS—osteoporosis	1.8e-05	0.000178	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—POMC—osteoporosis	1.8e-05	0.000178	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MGLL—osteoporosis	1.79e-05	0.000176	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—POMC—osteoporosis	1.78e-05	0.000175	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CALCA—osteoporosis	1.76e-05	0.000174	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—LRP5—osteoporosis	1.74e-05	0.000172	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TLN1—osteoporosis	1.74e-05	0.000172	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—MYC—osteoporosis	1.73e-05	0.000171	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—IL6R—osteoporosis	1.73e-05	0.000171	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—TGFB1—osteoporosis	1.73e-05	0.000171	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—IGF1—osteoporosis	1.71e-05	0.000169	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PGLS—osteoporosis	1.71e-05	0.000169	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GPD2—osteoporosis	1.71e-05	0.000169	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TLN1—osteoporosis	1.7e-05	0.000168	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—WNT1—osteoporosis	1.7e-05	0.000168	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—PTHLH—osteoporosis	1.7e-05	0.000167	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—IDH2—osteoporosis	1.69e-05	0.000167	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—LRP6—osteoporosis	1.67e-05	0.000165	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MGLL—osteoporosis	1.66e-05	0.000164	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PTHLH—osteoporosis	1.66e-05	0.000164	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—LRP5—osteoporosis	1.62e-05	0.00016	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CALCA—osteoporosis	1.61e-05	0.000159	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CYP27A1—osteoporosis	1.59e-05	0.000157	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ATIC—osteoporosis	1.56e-05	0.000154	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PNP—osteoporosis	1.56e-05	0.000154	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—ENO1—osteoporosis	1.56e-05	0.000154	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—LRP6—osteoporosis	1.55e-05	0.000153	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ACP5—osteoporosis	1.54e-05	0.000152	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PTHLH—osteoporosis	1.54e-05	0.000152	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PSMA2—osteoporosis	1.54e-05	0.000152	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PSMA5—osteoporosis	1.54e-05	0.000152	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—P4HB—osteoporosis	1.5e-05	0.000148	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CALCA—osteoporosis	1.49e-05	0.000147	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—POMC—osteoporosis	1.49e-05	0.000147	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—P4HB—osteoporosis	1.47e-05	0.000145	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PTH—osteoporosis	1.46e-05	0.000144	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CALCA—osteoporosis	1.46e-05	0.000144	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—TPI1—osteoporosis	1.44e-05	0.000142	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RAP1A—osteoporosis	1.44e-05	0.000142	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PTH—osteoporosis	1.43e-05	0.000141	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CNR2—osteoporosis	1.42e-05	0.000141	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—ADCY5—osteoporosis	1.41e-05	0.000139	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IL6—osteoporosis	1.41e-05	0.000139	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TLN1—osteoporosis	1.41e-05	0.000139	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RAP1A—osteoporosis	1.4e-05	0.000139	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NFATC1—osteoporosis	1.4e-05	0.000138	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CNR2—osteoporosis	1.39e-05	0.000137	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—DKK1—osteoporosis	1.39e-05	0.000137	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	1.38e-05	0.000137	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—POMC—osteoporosis	1.38e-05	0.000136	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—ADCY5—osteoporosis	1.38e-05	0.000136	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NFATC1—osteoporosis	1.37e-05	0.000135	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—DKK1—osteoporosis	1.36e-05	0.000134	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CALCA—osteoporosis	1.36e-05	0.000134	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—P4HB—osteoporosis	1.35e-05	0.000133	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—WNT1—osteoporosis	1.34e-05	0.000132	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CA2—osteoporosis	1.33e-05	0.000131	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—OXCT1—osteoporosis	1.33e-05	0.000131	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GAPDH—osteoporosis	1.32e-05	0.000131	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—WNT1—osteoporosis	1.31e-05	0.000129	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TLN1—osteoporosis	1.31e-05	0.000129	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—IL6—osteoporosis	1.31e-05	0.000129	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—IL6—osteoporosis	1.3e-05	0.000129	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FGA—osteoporosis	1.3e-05	0.000129	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—MGLL—osteoporosis	1.29e-05	0.000128	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—RAP1A—osteoporosis	1.29e-05	0.000127	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—ADCY5—osteoporosis	1.28e-05	0.000127	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FGA—osteoporosis	1.27e-05	0.000126	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—ADCY5—osteoporosis	1.25e-05	0.000124	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CYP19A1—osteoporosis	1.25e-05	0.000123	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—P4HB—osteoporosis	1.21e-05	0.00012	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—MYC—osteoporosis	1.21e-05	0.00012	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TGFB1—osteoporosis	1.21e-05	0.00012	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PTHLH—osteoporosis	1.21e-05	0.000119	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—BMP2—osteoporosis	1.21e-05	0.000119	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IL6—osteoporosis	1.19e-05	0.000118	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—IGF1—osteoporosis	1.19e-05	0.000117	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FGB—osteoporosis	1.18e-05	0.000117	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PTHLH—osteoporosis	1.18e-05	0.000117	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—BMP2—osteoporosis	1.18e-05	0.000117	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PTH—osteoporosis	1.18e-05	0.000117	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RAP1A—osteoporosis	1.16e-05	0.000115	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FGB—osteoporosis	1.16e-05	0.000114	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CNR2—osteoporosis	1.15e-05	0.000114	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	1.15e-05	0.000113	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—TGFB1—osteoporosis	1.15e-05	0.000113	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PSMA2—osteoporosis	1.14e-05	0.000113	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PSMA5—osteoporosis	1.14e-05	0.000113	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—ADCY5—osteoporosis	1.14e-05	0.000113	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NFATC1—osteoporosis	1.13e-05	0.000112	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—P4HB—osteoporosis	1.13e-05	0.000111	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—DKK1—osteoporosis	1.12e-05	0.000111	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PSMA2—osteoporosis	1.12e-05	0.00011	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PSMA5—osteoporosis	1.12e-05	0.00011	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—IDH2—osteoporosis	1.1e-05	0.000109	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PTH—osteoporosis	1.1e-05	0.000108	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—WNT1—osteoporosis	1.08e-05	0.000107	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RAP1A—osteoporosis	1.08e-05	0.000107	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CNR2—osteoporosis	1.07e-05	0.000106	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CALCA—osteoporosis	1.07e-05	0.000105	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—ADCY5—osteoporosis	1.06e-05	0.000105	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FGA—osteoporosis	1.05e-05	0.000104	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NFATC1—osteoporosis	1.05e-05	0.000104	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—DKK1—osteoporosis	1.04e-05	0.000103	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ENO1—osteoporosis	1.04e-05	0.000103	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CALCA—osteoporosis	1.04e-05	0.000103	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—POMC—osteoporosis	1.04e-05	0.000103	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—ADCY5—osteoporosis	1.04e-05	0.000102	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.03e-05	0.000102	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PSMA2—osteoporosis	1.03e-05	0.000101	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PSMA5—osteoporosis	1.03e-05	0.000101	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—MYC—osteoporosis	1.03e-05	0.000101	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TGFB1—osteoporosis	1.02e-05	0.000101	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—ADCY5—osteoporosis	1.02e-05	0.000101	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—POMC—osteoporosis	1.02e-05	0.0001	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GPX1—osteoporosis	1.02e-05	0.0001	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ACP5—osteoporosis	1.01e-05	9.93e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—WNT1—osteoporosis	1.01e-05	9.93e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PTHLH—osteoporosis	9.79e-06	9.67e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—BMP2—osteoporosis	9.79e-06	9.67e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FGA—osteoporosis	9.79e-06	9.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—KL—osteoporosis	9.67e-06	9.55e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—ADCY5—osteoporosis	9.64e-06	9.52e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FGB—osteoporosis	9.58e-06	9.46e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—KL—osteoporosis	9.46e-06	9.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—POMC—osteoporosis	9.44e-06	9.32e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—MTHFR—osteoporosis	9.38e-06	9.26e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—TPI1—osteoporosis	9.36e-06	9.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PSMA2—osteoporosis	9.25e-06	9.13e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PSMA5—osteoporosis	9.25e-06	9.13e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—POMC—osteoporosis	9.23e-06	9.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL6R—osteoporosis	9.21e-06	9.09e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IL6—osteoporosis	9.13e-06	9.01e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PTHLH—osteoporosis	9.1e-06	8.98e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—BMP2—osteoporosis	9.1e-06	8.98e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL6R—osteoporosis	9e-06	8.89e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FGB—osteoporosis	8.9e-06	8.79e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—P4HB—osteoporosis	8.8e-06	8.68e-05	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—IL6—osteoporosis	8.64e-06	8.53e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GAPDH—osteoporosis	8.63e-06	8.52e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CALCA—osteoporosis	8.62e-06	8.51e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PSMA2—osteoporosis	8.59e-06	8.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PSMA5—osteoporosis	8.59e-06	8.48e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—RAP1A—osteoporosis	8.41e-06	8.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—POMC—osteoporosis	8.41e-06	8.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CYP19A1—osteoporosis	8.34e-06	8.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CALCA—osteoporosis	8.01e-06	7.91e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—KL—osteoporosis	7.83e-06	7.73e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	7.81e-06	7.71e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—IL6—osteoporosis	7.72e-06	7.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—POMC—osteoporosis	7.64e-06	7.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ADCY5—osteoporosis	7.58e-06	7.48e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—POMC—osteoporosis	7.5e-06	7.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	7.45e-06	7.35e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ADCY5—osteoporosis	7.41e-06	7.32e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SPP1—osteoporosis	7.33e-06	7.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KL—osteoporosis	7.27e-06	7.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SPP1—osteoporosis	7.17e-06	7.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TGFB1—osteoporosis	7.13e-06	7.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—POMC—osteoporosis	7.09e-06	7e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	6.92e-06	6.83e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ADCY5—osteoporosis	6.81e-06	6.73e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ENO1—osteoporosis	6.8e-06	6.71e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GPX1—osteoporosis	6.79e-06	6.7e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PSMA5—osteoporosis	6.7e-06	6.61e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PSMA2—osteoporosis	6.7e-06	6.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IRS2—osteoporosis	6.63e-06	6.55e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—LEP—osteoporosis	6.49e-06	6.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IRS2—osteoporosis	6.49e-06	6.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—LEP—osteoporosis	6.35e-06	6.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—MTHFR—osteoporosis	6.27e-06	6.19e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ESR1—osteoporosis	6.2e-06	6.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	6.13e-06	6.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ESR1—osteoporosis	6.06e-06	5.98e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SPP1—osteoporosis	5.93e-06	5.86e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IRS1—osteoporosis	5.79e-06	5.71e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	5.7e-06	5.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IRS1—osteoporosis	5.66e-06	5.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—POMC—osteoporosis	5.57e-06	5.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SPP1—osteoporosis	5.51e-06	5.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—POMC—osteoporosis	5.45e-06	5.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL6R—osteoporosis	5.44e-06	5.37e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP19A1—osteoporosis	5.43e-06	5.36e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IRS2—osteoporosis	5.37e-06	5.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IGF1—osteoporosis	5.36e-06	5.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL6R—osteoporosis	5.32e-06	5.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—LEP—osteoporosis	5.25e-06	5.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IGF1—osteoporosis	5.25e-06	5.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ESR1—osteoporosis	5.01e-06	4.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—POMC—osteoporosis	5.01e-06	4.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IRS2—osteoporosis	4.98e-06	4.92e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—LEP—osteoporosis	4.88e-06	4.82e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IRS1—osteoporosis	4.68e-06	4.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ESR1—osteoporosis	4.66e-06	4.6e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—POMC—osteoporosis	4.51e-06	4.45e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ADCY5—osteoporosis	4.44e-06	4.38e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GPX1—osteoporosis	4.42e-06	4.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL6R—osteoporosis	4.4e-06	4.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IRS1—osteoporosis	4.35e-06	4.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IGF1—osteoporosis	4.34e-06	4.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—POMC—osteoporosis	4.19e-06	4.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL6—osteoporosis	4.1e-06	4.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL6R—osteoporosis	4.09e-06	4.04e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—MTHFR—osteoporosis	4.08e-06	4.03e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IGF1—osteoporosis	4.03e-06	3.98e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL6—osteoporosis	4.01e-06	3.96e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL6—osteoporosis	3.32e-06	3.28e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—POMC—osteoporosis	3.27e-06	3.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MYC—osteoporosis	3.22e-06	3.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TGFB1—osteoporosis	3.21e-06	3.17e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MYC—osteoporosis	3.15e-06	3.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TGFB1—osteoporosis	3.14e-06	3.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL6—osteoporosis	3.08e-06	3.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MYC—osteoporosis	2.61e-06	2.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	2.6e-06	2.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MYC—osteoporosis	2.42e-06	2.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL6—osteoporosis	2.42e-06	2.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	2.42e-06	2.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL6—osteoporosis	2.37e-06	2.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL6—osteoporosis	1.96e-06	1.93e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL6—osteoporosis	1.82e-06	1.8e-05	CbGpPWpGaD
